Abstract: The present invention provides compounds and methods for modulating transcription activated by ?-catenin/TCF, such as the selective inhibition of genes targeted by the Wnt/?-catenin pathway.
Type:
Grant
Filed:
August 27, 2004
Date of Patent:
May 12, 2009
Assignee:
Choongwae Pharma Corporation
Inventors:
Michael Kahn, SeWoong Oh, DaeHoon Kim, JongRyul Ha, Katayoon Hojjati-Emami